178 related articles for article (PubMed ID: 1679661)
21. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
Milne RJ; Buckley MM
Drugs; 1991 Jun; 41(6):941-69. PubMed ID: 1715268
[TBL] [Abstract][Full Text] [Related]
22. Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.
Felix SB; Stangl V; Kieback A; Doerffel W; Staudt A; Wernecke KD; Baumann G; Stangl K
J Cardiovasc Pharmacol; 2001 Nov; 38(5):666-71. PubMed ID: 11602813
[TBL] [Abstract][Full Text] [Related]
23. Celiprolol and atenolol in angina--effects on left ventricular function.
Dargie H; McLenachan JM; Wilson JT
J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
[TBL] [Abstract][Full Text] [Related]
24. Celiprolol in angina pectoris.
Soberman JE; Frishman WH
Am Heart J; 1988 Nov; 116(5 Pt 2):1422-5. PubMed ID: 2903653
[TBL] [Abstract][Full Text] [Related]
25. Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise.
Nesto RW; White HD; Ganz P; Koslowski J; Wynne J; Holman BL; Antman E
Am J Cardiol; 1985 May; 55(12):3E-8E. PubMed ID: 3923813
[TBL] [Abstract][Full Text] [Related]
26. Clinical, electrocardiographic, and hemodynamic effects of ICI 89,406, a new cardioselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, in patients with angina pectoris.
Majid PA; Schreuder JE; de Feyter PJ; Roos JP
J Cardiovasc Pharmacol; 1980; 2(4):435-44. PubMed ID: 6156341
[TBL] [Abstract][Full Text] [Related]
27. Celiprolol and the heart.
Taylor SH
Am J Cardiol; 1988 Feb; 61(5):34C-40C. PubMed ID: 2893532
[TBL] [Abstract][Full Text] [Related]
28. Clinical and hemodynamic effects of combined propranolol and nifedipine therapy versus propranolol alone in patients with angina pectoris.
Braun S; Terdiman R; Berenfeld D; Laniado S
Am Heart J; 1985 Mar; 109(3 Pt 1):478-85. PubMed ID: 3976473
[TBL] [Abstract][Full Text] [Related]
29. Clinical perspective on celiprolol: cardioprotective potential.
Frishman WH
Am Heart J; 1991 Feb; 121(2 Pt 2):724-9. PubMed ID: 1671192
[TBL] [Abstract][Full Text] [Related]
30. Effects of Adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: comparative study with propranolol.
Kurita A; Ogawa T; Kanazawa M; Hamamato H; Mabuchi G
Cathet Cardiovasc Diagn; 1976; 2(4):361-7. PubMed ID: 1000624
[TBL] [Abstract][Full Text] [Related]
31. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
Klein W; Fluch N; Brandt D
Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic effects of celiprolol in essential hypertension.
Frohlich ED; Ketelhut R; Kaesser UR; Losem CJ; Messerli FH
Am J Cardiol; 1991 Aug; 68(5):509-14. PubMed ID: 1678580
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamic and adrenergic effects of combined alpha/beta-receptor blockade versus combined beta-receptor and slow channel calcium blockade in patients with ischemic heart disease.
Koch G; Fransson L
Int J Cardiol; 1989 Oct; 25(1):73-9. PubMed ID: 2793265
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period].
Klinger D
Wien Med Wochenschr; 1987 Jun; 137(12):278-86. PubMed ID: 2887073
[TBL] [Abstract][Full Text] [Related]
35. [The acute hemodynamic effects of the new vasodilating beta blocker carvedilol in comparison with combined administration of nifedipine and propranolol in patients with coronary heart disease].
Mauser M; Voelker W; Ickrath O; Hoffmeister HM; Karsch KR
Z Kardiol; 1989 Nov; 78(11):726-31. PubMed ID: 2609718
[TBL] [Abstract][Full Text] [Related]
36. Improved left ventricular function during exercise: a comparison of celiprolol and atenolol.
McLenachan J; Wilson J; Dargie H
Am Heart J; 1988 Nov; 116(5 Pt 2):1435-6. PubMed ID: 2903655
[No Abstract] [Full Text] [Related]
37. Improvement in exercise capacity and associated changes in hemodynamics and left ventricular function after the addition of metoprolol to nifedipine in patients with stable exertional angina.
Choong CY; Roubin GS; Shen WF; Tokuyasu Y; Harris PJ; Kelly DT
Clin Cardiol; 1985 Apr; 8(4):213-24. PubMed ID: 3987110
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
[TBL] [Abstract][Full Text] [Related]
39. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
Koch G
Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.
Savonitto S; Ardissiono D; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Wahlqvist I; Merlini PA; Rehnqvist N
J Am Coll Cardiol; 1996 Feb; 27(2):311-6. PubMed ID: 8557899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
